Accendra Health, Inc. Q1 2026 Earnings Call Transcript
Accendra Health, Inc. (ACH) held its First Quarter 2026 Earnings Conference Call on May 11, 2026. The call featured key company executives, including President and CEO Edward Pesicka, Executive VP and CFO Jonathan Leon, and Executive VP and COO Perry Bernocchi. Will Parrish, Vice President of Strategy, Corporate Development, and Investor Relations, opened the session by welcoming participants and outlining the agenda. He emphasized that discussions would center on the financial results for the first quarter of 2026, as detailed in the accompanying press release and supplemental slides available on the company's Investor Relations website. Parrish also issued standard legal disclaimers regarding forward-looking statements, noting that these projections reflect current views but are subject to risks and uncertainties that could cause actual results to differ materially. The transcript includes participation from major financial analysts representing institutions such as UBS Investment Bank, Citigroup Inc., Leerink Partners LLC, and BofA Securities. This document serves as a record of the corporate presentation and subsequent question-and-answer session, providing stakeholders with insights into Accendra Health's recent financial performance and strategic outlook for the remainder of the fiscal year.
Wire timeline
Accendra Health, Inc. Q1 2026 Earnings Call Transcript
Accendra Health, Inc. (ACH) held its First Quarter 2026 Earnings Conference Call on May 11, 2026. The call featured key company executives, including President and CEO Edward Pesicka, Executive VP and CFO Jonathan Leon, and Executive VP and COO Perry Bernocchi. Will Parrish, Vice President of Strategy, Corporate Development, and Investor Relations, opened the session by welcoming participants and outlining the agenda. He emphasized that discussions would center on the financial results for the first quarter of 2026, as detailed in the accompanying press release and supplemental slides available on the company's Investor Relations website. Parrish also issued standard legal disclaimers regarding forward-looking statements, noting that these projections reflect current views but are subject to risks and uncertainties that could cause actual results to differ materially. The transcript includes participation from major financial analysts representing institutions such as UBS Investment Bank, Citigroup Inc., Leerink Partners LLC, and BofA Securities. This document serves as a record of the corporate presentation and subsequent question-and-answer session, providing stakeholders with insights into Accendra Health's recent financial performance and strategic outlook for the remainder of the fiscal year.
All Articles on Seeking Alpha